Revenue from Contracts with Customers (Tables)

3 Months Ended

Apr. 01, 2022

Disaggregation of Revenue [Line Items]

Sales Reserves Rollforward

The following table reflects activity in the Company's sales reserve accounts:

	Rebates and Chargebacks		Product Returns		Other Sales Deductions		Total
Balance as of December 25, 2020	$	196.5	$	26.6	$	12.3	$	235.4
Provisions (1)	488.0		25.7		13.0		526.7
Payments or credits	(442.9)		(10.0)		(14.9)		(467.8)
Balance as of March 26, 2021	$	241.6	$	42.3	$	10.4	$	294.3
Balance as of December 31, 2021	$	241.8	$	21.5	$	9.5	$	272.8
Provisions	370.8		2.4		9.7		382.9
Payments or credits	(412.0)		(4.3)		(10.0)		(426.3)
Balance as of April 1, 2022	$	200.6	$	19.6	$	9.2	$	229.4

(1)Provision for returns decreased by $23.3 million driven by the Specialty Brands segment primarily related to a discrete return of product during the three months ended March 26, 2021.

Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:

	Three Months Ended
	April 1, 2022		March 26, 2021
Product sales transferred at a point in time	79.5	%	75.7	%
Product sales transferred over time	20.5		24.3

The associated royalty revenue recognized was as follows:

	Three Months Ended
	April 1, 2022		March 26, 2021
Royalty revenue	$	20.0	$	35.4

Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of April 1, 2022:

Remainder of Fiscal 2022	$	69.6
Fiscal 2023	71.2
Fiscal 2024	17.5
Thereafter	0.3